Strategy

News

BioMarin's new hires Greg Friberg (l) and James Sabry (r)

BioMarin revamps leadership with ex-Roche, Amgen execs

BioMarin Pharmaceutical has made a couple of appointments aimed at boosting its pipeline, both internally and externally, with C-suite appointments in charge of R&D and business develop

News

Bayer CEO says recovery on track as key drug products shine

Bayer has joined its peers among European drugmakers with a hike in pharma forecasts for the year, as it recorded a rise in group sales, but lower profits for the second quarter.

Digital

navigating intellectual property challenges

Risk management strategies to navigate IP challenges associa...

Artificial intelligence (AI) is revolutionising industries. But with this exciting new frontier comes a complex challenge: protecting your intellectual property (IP).

Sales & Marketing

Behavioural science in biopharma: Convincing backers and phy...

Novel therapies, often with expensive price tags and finite patient populations, require strategic new positioning if they are to have maximum positive impact.